DiaMedica Therapeutics Inc.
NASDAQ:DMAC · NASDAQ Capital Market
-$0.01 today
Vol 0.23M · Avg 0.19M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+60.27%
Period High
$9.39
Period Low
$3.57
Latest
$5.85
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alpha Tau Medical Ltd.
NASDAQ:DRTS
$867.13M
Design Therapeutics, Inc.
NASDAQ:DSGN
$758.85M
Annexon, Inc.
NASDAQ:ANNX
$587.93M
DBV Technologies S.A.
NASDAQ:DBVT
$382.97M
Altimmune, Inc.
NASDAQ:ALT
$239.18M
I-Mab
IMAB
$235.66M
Galectin Therapeutics Inc.
NASDAQ:GALT
$184.21M
Korro Bio, Inc.
NASDAQ:KRRO
$128.40M
Genelux Corporation
NASDAQ:GNLX
$110.03M
enGene Holdings Inc.
NASDAQ:ENGN
$88.06M
What is the latest DMAC filing?
The latest filing shown is 8-K dated May 21, 2026.
How many recent filings does DMAC have?
Intrinsic Alpha currently shows 20 recent filings for DMAC.
Explore More
Continue the stock analysis
Jump to another research area for this company.